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The epidemiology of respiratory human bocavirus (HBoV) infection has not
been described in Tehran’s adult and to determine the epidemiological and clinical
characteristics associated with HBoV infection, a population of adults hospitalized with
respiratory tract infections were chosen. Throat swab samples were collected from 91
hospitalized adults aged between 29 to 91 year and Real-time PCR TaqMan was used to
screen specimens by amplifying a part of the NP1 gene.  HBoV was detected in 6 adults
(6.6%).  Mean age was 76 years and 67% of patients were female. The most common
symptoms were wheezing (100%), tachypnea (100%), cough (100%), rhinorrhea/pharyngitis
(83.33%) and fever (83.33%) which clinically diagnosed by a physician. Gastrointestinal
symptoms was present only in 1 patient (16.6%). In our study the distribution of HBoV
was influenced by temperature, relative humidity and precipitation. HBoV is circulating
in Tehran and is associated with both upper and lower respiratory tract disease in
adults.
Key words: Respiratory Infections, Adults, Human Bocavirus, Real-time PCR.
Etiology of respiratory tract infections is
diverse and several novel respiratory viruses are
continuously being reported. New respiratory
viruses such as Human Metapneumovirus,
Coronaviruses NL63 and HKU1, SARS
Coronavirus and Human Bocaviruses have been
discovered during the past decade. The availability
of molecular diagnostics assays and using
conventional virological diagnostic techniques has
importantly increased our ability to detect and
characterize the epidemiology of respiratory virus
infections1-5.
Human bocavirus belongs to the
genusbocavirus, family parvoviridae, and is a non-
enveloped, round (19-22 nm) and icosahedral in
symmetry with a small genome size of 5.3 kilo-bases
(kb). Genome itself has 3 ORFs encoding two non-
structural proteins (NS1,NP1) and two structural
proteins (VP1, VP2)6,7. The virus exists in 4 different
serotypes, unlike HBoV1 which has been primarily
detected in respiratory samples8-10, the newer
viruses (HBoV2, 3, 4) have been found frequently
in human stool samples8,12,13. Parvoviruses are
capable of systematic infections, in order to
replicate they need proliferating host cells, so
infection of respiratory and gut epithelium,
hematopoietic cells and transplacental infection
of fetuses are frequent characteristics of this family.
Therefore they can be associated with respiratory
tract infections13. Subsequently HBoV was
reported in 1.5% - 8.3% of respiratory samples with
acute respiratory tract illness (ARTI) from different
countries and regions worldwide9-11,14-18. Primary
infections with HBoV happens early in life
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(childrenbetween 6-24 month) and these infections
are rarely found in adults19-20. Detection of HBoV
mostly relies on classical and Real-time PCR21-23
on nasopharyngeal aspirates and swabs19,21,24-27.
The current study aims to screen the
epidemiological and clinical status of HBoV
isolates in adult patients suffering from acute and
lower respiratory tract illness in Tehran, Iran.
Patients and Specimen Collection
During winter and spring (January to June
2014) 91 samples were collected from adults
hospitalized with respiratory infections. The cross-
sectional study population aged between 29 to 91
years. All specimens were collected from Tehran’s
hospitals with informed consents from the patients
during their hospital stay and as the part of the
diagnosis , pneumonia , bronchiolitis , asthma ,
acute nasopharyngitis , chest retraction were
diagnosed by the physician through physical
examinations and chest X-Rays . Patients with
immune-compromised conditions like
chemotherapy or immunosuppressive therapy,
bone marrow transplantation were all excluded from
this study. Throat swab specimens were collected
from each patient and stored in a viral transport
medium. Samples were transported to the virology
laboratory of Iran University of Medical Sciences
immediately and stored at -70°c until use. All
patients’ medical records, demographic and clinical
data including detailed signs and symptoms and
laboratory results were collected.
Nucleic Acid Extraction
Viral nucleic acid extraction was
performed in a “clean room” facility within the
medical virology department (Iran University of
Medical Sciences), by using an Invisorb® Spin
Virus DNA mini Kit (Stratec molecular, Germany)
according to the manufacturer’s instructions. After
extraction, the elution volume (100µL) stored at -
20°c for subsequent analyses.
Real-Time Polymerase Chain Reaction
The Real-Time PCR assay with
hydrolyses TaqMan Probe was performed using a
commercial, Real Q-PCR 2x Master mix Kit
(Amplicon, Denmark) in Bio-Rad CFX96. Real-Time
PCR primer and Probes were as follows :
Forward primer: 5'-AGA GGC TCG GGC TCA
TATCA-3'
Reverse primer: 5'-CAC TTG GTC TGA GGT
CTTCGAA- 3'
Probe: 5'-FAM-AGG ACC ACC CAA TCARCC
ACCTAT CGTCT-TAMRA-3'
Where FAM is 6-carboxyfluorescein and
TAMRA is 6-carboxytetramethylrhodamine. The
amplification reaction mixture was conducted by
4µL of extracted specimen, 10µL TaqMan universal
PCR master mix (PE applied bio systems), 0.1µL
bovine serum albumin (20
mg/ml
),300
nmol/liter
 of each
primerand 150
nmol/liter
 of Boca probe. After 15 min at
95°c, 40 cycles of amplification (95°c for 20
sec
 - 55°cfor
20
sec
 - 72°cfor 40
sec
) were performed. HBoV positive
samples were confirmed.
Statistical analysis
Comparisons were made by using Fisher’s
exact test for 2x2 tables and T-Independenttests.
All test’s P-value<0.05 were considered statistical
significant.
RESULTS
1. Demographic characteristics of patients:
The HBoV testing was performed on throat
swab specimens which was collected during
respiratory infections from 91 hospitalized
adults with an age ranging from 29 to 91
years. Since the seasonal distribution of
HBoV was noted during the winter and
spring and HBoV is detectable less
frequently in adults, data are scarce among
the elderly. This study’s seasonal
distribution is demonstrated in Fig1 which
shows HBoV to be predominant in March.
The male to female ratio of the 6, HBoV
positive adults was 2:4 and all 6 patients
were older than 60 years of age (Table 1).
2. Clinical and Laboratory Findings : The
clinical characteristics of the patients are
listed in Table 2 which illustrates , most
patients have symptoms of upper
respiratory tract illness (URTI) including
cough (100%), rhinorrhea (83%) and in less
frequently there were symptoms of lower
respiratory tract illness (LRTI) including
pneumonia (67%) , bronchiolitis and
bronchitis (50%) which were diagnosed by
chest radiography and sputum culture
requested by physician .Table 3 represents
clinical and laboratory findings of all
patients in HBoV positive and Negative
groups . Alanine aminotransferase (ALT),
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Table 2. Symptoms and clinical diagnosis among
6 episodes associated with HBoV infection
N(%) P-value
Fever>38.5°C 5 (83.33 %)
Cough 6 (100 %)
Rhinorrhea/Pharyngitis 5 (83.33 %)
Shortness of breath 4 (66.66 %)
Gastrointestinal symptoms 1 (16.66 %)
Asthma 2 (33.33 %)
Bronchiolitis and bronchitis 3 (50 %)
Pneumonia 4 (66.66 %)
Wheezing 6 (100 %)
Chest retraction 2 (33.33 %)
Tachypnea 6 (100 %)
Neurological disorder 4 (66.66 %)
Table 1. Demographic data of adults suffered from
respiratory distress in the current  study
Variable Value HBoV infected
Age 28-91 yr
28-41 yr 7 0
42-51 yr 6 0
52-61 yr 15 0
62-71 yr 16 2
72-81 yr 29 2
82-91 yr 18 2
Gender
Male 51 2
Female 40 4
Table 3. Clinical and laboratory findings of patients
Clinical data HBoV+(n=6) HBoV-(n=85) P-value
Age 75.83 ± 9.23 68.32 ± 15.79 0.255
White blood cells 12066.66 ± 9625.52 12396.47 ± 20160.44 0.969
Neutrophils (%) 83.33 ± 9.6 77.44 ± 10.5 0.187
Lymphocytes (%) 12.83 ± 7.3 17.79 ± 9.1 0.182
Platelet count (/mm3) 197500 ± 117974 238156.47 ± 92497.19 0.309
C-reactive protein (mg/dl) 1.66 ± 1.03 4.58 ± 13.13 0.59
SGOT(IU/I) 20 ± 8.36 30.51 ± 23.08 0.272
SGPT(IU/I) 19.16 ± 8.61 31.61 ± 47.58 0.526
ESR(mm/hr) 10.83 ± 6.99 16.17 ± 12.20 0.294
Albomin (g/dl) 2.95 ± 0.13 3.82 ± 6.54 0.746
Gender (female %) 66.66 42.35 0.399
Neurologic disorder (%) 6.3 93.7 0.554
Wheezing (%) 6.2 93.8 0.656
Chest retraction (%) 5.8 94.2 0.152
Tachypnea (%) 6.1 93.9 0.61
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Fig. 1. Monthly distribution of HBoV from January to June 2014
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Aspartate aminotransferase (AST), ESR,
platelet count in both groups were within
the normal ranges; while White-Blood-
Count (WBC), Neutrophils, C-reactive
protein (CRP) and albumin were higher and
lymphocytes were less than normal ranges.
Frequency of wheezing and tachypnea were
significantly higher in HBoV positive group
and all 6 patients had these 2 symptoms. 2
of HBoV positive patients had chest
retraction and 4 of them had neurological
disorders.
Beside these findings, there was a
significant difference (according to the P-value)
between cough symptom among HBoV positive
and negative patients (P= .021).
DISCUSSION
Human bocavirus is one of the new
emerging viruses for the past decade which was
first described by Allander et all in 2005 , since
that time lots of studies occurred throughout the
world and only a few ones have described the
characteristics of HBoV infection in elderly11,19,24,25.
This study evaluate the characteristics of HBoV
positive adults suffered from respiratory tract
illness with a wide age distribution from
Tehran,Iran for the first time.
In our study all of the patients with HBoV
infections were older than 62 years of age as Liu et
al also demonstrated the same data in china32 which
suggested that old people are also susceptible to
HBoV infection but data are scarce on the
occurrence and consequences of HBoV infection
among the elderly11,19,24,28,33-38.
As most studies found that peak
occurrence of HBoV infection are throughout
spring and winter6,15,21,25,27-30,33-36,39-45 on this cross-
sectional study we focused on these 2 seasons to
collect samples and the peak for HBoV infection
was in April. Yet gender specific differences have
not been reported46.
Previous studies have implicated HBoVas
a cause of RTI. With respect to the clinical features
of HBoV infection , there were 8 major symptoms
among HBoV positive group including cough ,fever
> 38.5% , wheezing , tachypnea , neurologic
disorder , pneumonia , shortness of breath ,
rhinorrhea/pharyngitis which had the highest ratio
(50%) in compared with the HBoV negative group
( Table 2) . Also in several studies it has been
mentioned that the frequent occurrence of lower
respiratory tract symptoms especially wheezing
indicates HBoV maybe a significant cause of
asthma exacerbation23-25,29-31,43,47-54. It must be
considered that the presence of HBoV in airway
epithelium may not be able to interpret its role as a
pathogen and co-infection with other viruses in
elderly are common. therefore serology is
suggested to be a useful diagnostic in addition to
the study of HBoV infection because of high
seroprevalence rate against HBoV in adult
population13,55, also detection of HBoV viremia ,
viral loads in quantitative PCR are more useful
prophesiers of HBoV associated clinical disease
than only qualitative detection of HBoV DNA in
respiratory tract samples .
In conclusion, the present study provided
a first insight into the epidemiology and clinical
aspects of HBoV infection in hospitalized adults
in Tehran. Our findings indicate disease associated
with HBoV range from pharyngitis to bronchitis,
asthma and even pneumonia and in seasonal
pattern with HBoV cases peak months are within
January and June.
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